TMSH (TransGlobal Assets) EBITDA Margin %: -439.02% (As of Dec. 2011)


What is TransGlobal Assets EBITDA Margin %?

TransGlobal Assets TMSH EBITDA Margin % is -439.02% as of Dec. 2011.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. TransGlobal Assets's EBITDA for the six months ended in Dec. 2011 was $-0.54 Mil. TransGlobal Assets's Revenue for the six months ended in Dec. 2011 was $0.12 Mil. Therefore, TransGlobal Assets's EBITDA margin for the quarter that ended in Dec. 2011 was -439.02%.

TransGlobal Assets  (OTCPK:TMSH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

TransGlobal Assets EBITDA Margin % Related Terms

TransGlobal Assets EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for TransGlobal Assets's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TransGlobal Assets EBITDA Margin % Chart

TransGlobal Assets Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
EBITDA Margin %
0.00 0.00 0.00 0.00 -439.02

TransGlobal Assets Semi-Annual Data
Dec07 Dec08 Dec09 Dec10 Dec11
EBITDA Margin % 0.00 0.00 0.00 0.00 -439.02

TMSH vs CLDOF: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TransGlobal Assets's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TransGlobal Assets EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TransGlobal Assets's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where TransGlobal Assets's EBITDA Margin % falls into.


TransGlobal Assets EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

TransGlobal Assets's EBITDA Margin % for the fiscal year that ended in Dec. 2011 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2011 )/Revenue (A: Dec. 2011 )
=-0.54/0.123
=-439.02 %

TransGlobal Assets's EBITDA Margin % for the quarter that ended in Dec. 2011 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2011 )/Revenue (Q: Dec. 2011 )
=-0.54/0.123
=-439.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -439.02% mean?
TransGlobal Assets (TMSH) has a EBITDA Margin % of -439.02% as of Dec. 2011. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TransGlobal Assets and its competitors.
Is TransGlobal Assets' EBITDA Margin % too high?
TransGlobal Assets' current EBITDA Margin % is -439.02%.
How does TransGlobal Assets' EBITDA Margin % compare to CLDOF?
TransGlobal Assets' EBITDA Margin % of -439.02% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TransGlobal Assets and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TransGlobal Assets's current EBITDA Margin % is -439.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransGlobal Assets stock overvalued right now?
TransGlobal Assets (TMSH) has a current EBITDA Margin % of -439.02%. The current EBITDA Margin % is -439.02%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For TransGlobal Assets (TMSH), the current EBITDA Margin % is -439.02% as of Dec. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TransGlobal Assets Business Description

Address No. 14, 5555 Sagamore Avenue, Portsmouth, NH, USA, 03801
TransGlobal Assets Inc through its subsidiary Mindwell Solutions Group LLC (MWSG), the company develops proprietary solutions that harness AI, biometric analysis, and behavioral data to address high-growth markets, including mental health, relationship wellness, performance analytics, and sports/entertainment. and also offers a pioneer in transforming the health and wellness industries through cutting-edge products and services. The products and services are focused on being at the forefront of the health and wellness sectors, developing technologies and solutions that are driving industry growth and transforming lives. The portfolio includes a range- of-products and services, from telemedicine platforms to wellness retreats and natural health remedies.